Monday November 23 2009 | Biotechnology feed | All feeds

«Alexion Pharmaceuticals Incorporated

Below is an extended Alexion Pharmaceuticals Incorporated patents listing. Click here to return to the Alexion Pharmaceuticals Incorporated main Biocorporate entry.

Alexion Pharmaceuticals Incorporated Patents :
US Patent No.	Title
7598353	Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
6803230	Phagemid vectors
6498285	Methods for producing transgenic pigs by microinjecting a blastomere
6355245	C5-specific antibodies for the treatment of inflammatory diseases
6338820	Apparatus for performing assays at reaction sites
6074642	Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
6040428	Porcine E-selectin
5891645	Porcine E-selectin
5871997	Methods and compositions for protecting retroviral vector particles and producer cells from inactivation by complement via reduction of the expression or recognition of galactose alpha (1,3) galactosyl epitopes
5853722	Use of C5-specific antibodies for reducing immune and hemostatic dysfunctions during extracorporeal circulation
5847082	Terminal complement inhibitor fusion proteins
5643770	Retroviral vector particles expressing complement inhibitor activity
5627264	Chimeric complement inhibitor proteins
5624837	Nucleic acid encoding chimeric complement inhibitor proteins
5580766	Retroviral vector particles for transducing non-proliferating cells
5576201	Retroviral vector particles for transducing non-proliferating cells
6919189	Nested oligonucleotides containing a hairpin for nucleic acid amplification
6982323	Chimeric proteins for diagnosis and treatment of diabetes
7598030	Antibodies against cancer produced using masked cancer cells as immunogen
7482435	Rationally designed antibodies
7435412	Chronic lymphocytic leukemia cell line
7427665	Chronic lymphocytic leukemia cell line
7414111	Engineered templates and their use in single primer amplification
7408041	Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
7405279	Chimeric proteins for diagnosis and treatment of diabetes
7399594	Hybrid antibodies
7396917	Rationally designed antibodies
7393648	Hybrid antibodies
7384915	Chimeric insulin-gad proteins for treating patients with type 1 diabetes or at risk of developing type 1 diabetes
7361339	Methods for reducing morality associated with acute myocardial infarction
7306906	Engineered templates and their use in single primer amplification
7279158	Methods for the treatment of inflammatory joint disease
7041503	Modified myelin basic protein molecules
5562904	Retroviral transduction of cells using soluble complement inhibitors

«Alexion Pharmaceuticals Incorporated

This page contained an extended Alexion Pharmaceuticals Incorporated patents listing. Click here to return to the Alexion Pharmaceuticals Incorporated main Biocorporate entry.

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

«Alexion Pharmaceuticals Incorporated

Below is an extended Alexion Pharmaceuticals Incorporated patents listing. Click here to return to the Alexion Pharmaceuticals Incorporated main Biocorporate entry.

Alexion Pharmaceuticals Incorporated Patents :

«Alexion Pharmaceuticals Incorporated

This page contained an extended Alexion Pharmaceuticals Incorporated patents listing. Click here to return to the Alexion Pharmaceuticals Incorporated main Biocorporate entry.